David Hermanson
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- CAR-T cell therapy research 15
-
- Cancer therapeutics and mechanisms 4
- Pluripotent Stem Cells Research 3
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 3
- Co-authors
- Dan S. Kaufman (7 shared papers)Branden S. Moriarity (2 shared papers)Ye Li (1 shared paper)Laura E. Bendzick (4 shared papers)Chengguo Xing (8 shared papers)Zhenya Ni (2 shared papers)David A. Knorr (2 shared papers)Melinda K. Hexum (1 shared paper)
- Journals
- Blood (8 papers)Journal of Medicinal Chemistry (3 papers)Molecular Pharmacology (2 papers)Cancer Research (2 papers)Stem Cells Translational Medicine (2 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
David Hermanson
29 papers receiving 1.9k citations
David Hermanson's Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 1.1k
- Oncology 1.2k
- Hematology 139
- Toxicology 33
- Molecular Biology 533
Countries citing papers authored by David Hermanson
This map shows the geographic impact of David Hermanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hermanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hermanson more than expected).
Fields of papers citing papers by David Hermanson
This network shows the impact of papers produced by David Hermanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hermanson. The network helps show where David Hermanson may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hermanson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity Hit paper breakdown → | 2018 | 772 |
| 2 | 2013 | 321 | |
| 3 | 2015 | 192 | |
| 4 | 2015 | 139 | |
| 5 | 2009 | 67 | |
| 6 | 2011 | 52 | |
| 7 | 2009 | 43 | |
| 8 | 2012 | 43 | |
| 9 | 2013 | 37 | |
| 10 | 2016 | 30 | |
| 11 | 2022 | 26 | |
| 12 | 2009 | 26 | |
| 13 | 2011 | 25 | |
| 14 | 2012 | 24 | |
| 15 | 2010 | 22 | |
| 16 | 2016 | 17 | |
| 17 | 2007 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2013 | 8 |
About David Hermanson
David Hermanson is a scholar working on Oncology, Molecular Biology, Immunology, Organic Chemistry and Hematology, having authored 30 papers that have together received 1.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (10 papers), Cancer therapeutics and mechanisms (4 papers), Pluripotent Stem Cells Research (3 papers), T-cell and B-cell Immunology (3 papers), Synthesis and biological activity (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.2k citations), Hematology (139 citations), Toxicology (33 citations) and Molecular Biology (533 citations). David Hermanson has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Dan S. Kaufman, Branden S. Moriarity, Ye Li, Laura E. Bendzick, Chengguo Xing, Zhenya Ni, David A. Knorr, Melinda K. Hexum, Laurence J.N. Cooper and Dean A. Lee. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, Molecular Pharmacology, Cancer Research and Stem Cells Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.